RxDoctor Payments Data

Christopher Conrad, MD

Family Medicine · Fort Wayne, INNPI 1386728863

Payments from drug & device makers

$393in general payments, 2019–2025

Across 37 payments — averaging $10.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$167
  • Amgen$50
  • AstraZeneca$42
  • Teva Pharmaceuticals USA, Inc.$25
  • Boehringer Ingelheim$23
  • Daiichi Sankyo Inc.$22
  • plus $64 from 5 others

What the payments were for

  • Food & beverage$393100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$393 in reported general payments places this provider in the 40th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$84,943
Medicare patients
279
Services billed
3,146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide153$188,119
MounjaroTirzepatide90$109,983
JardianceEmpagliflozin87$93,930
EliquisApixaban43$60,519
FarxigaDapagliflozin Propanediol38$53,810
TrulicityDulaglutide29$50,825
JanuviaSitagliptin Phosphate27$42,937
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr41$26,111
Janumet XrSitagliptin Phos/Metformin Hcl18$23,360
Tresiba Flextouch U-100Insulin Degludec29$22,004
TradjentaLinagliptin23$19,130
LinzessLinaclotide12$16,777
Breo ElliptaFluticasone/Vilanterol35$15,878
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$13,018
Repatha SureclickEvolocumab14$12,850

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$167$188,119153 claims
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$23$124,366132 claims
AstraZenecaFarxiga, Symbicort$42$63,68976 claims
PfizerEliquis$13$60,51943 claims
GSKAnoro Ellipta, Breo Ellipta, Trelegy Ellipta$13$55,00795 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Fort Wayne

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →